drugset / Trial / NCT01678573
A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics (how the drug concentrations change over time) of abiraterone acetate after oral administration of abiraterone acetate at different dose levels of 250, 500, and 1000 mg in healthy Chinese male participants under fasted conditions.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | 250 mg | Oral |
| Subject | Abiraterone acetate | Small molecule | 500 mg | Oral |
| Subject | Abiraterone acetate | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.